Marriage Counselors in Shelby, NC Accepting Medicare

7 Marriage Counselors found. Showing 1 - 7

Mrs. Michele Christine Blackman, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 809 N Lafayette St, Suite A, Shelby, NC 28150 Phone: 704-284-0554

Mrs. Sejal Rayna Patel, LMFTA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 802 N Lafayette St, Shelby, NC 28150 Phone: 704-865-3525

Mrs. Kimberly Ann Whalen, LMFTA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 809 N Lafayette St, Suite A, Shelby, NC 28150 Phone: 704-284-0554    Fax: 704-448-2003

Mr. Stanley Todd Bilin, LMFTA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1243-4 East Dixon Blvd, Shelby, NC 28152 Phone: 704-487-4000    Fax: 704-487-4005

Angie Nicole Baquedano, LMFTA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 331 S Washington St Ste 201, Shelby, NC 28150 Phone: 980-484-3470

Celena Haaland Ditz Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 425c Cherryville Rd, Shelby, NC 28150 Phone: 704-484-2558    Fax: 704-484-2042

Mary Johnson Utsman, LMFT-A Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 809 N Lafayette St Ste 200, Shelby, NC 28150 Phone: 704-284-0554

News Archive

Study: Certain prostate cancer medications linked to cardiac death risk

A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks. Published in BJU International, the findings will help doctors and patients weigh the benefits and risks of the drugs.

Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced it has signed a non-exclusive license agreement with GlaxoSmithKline ("GSK"). Under the terms of the agreement, GSK gains certain rights to Response Genetics' proprietary PCR analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples. Payments will be made to Response Genetics upon achivement of agreed-to milestones.

Providing cancer patients with counseling before and after testing for genetic mutations decreases anxiety

Many BRCA 1/2-negative patients choose to proceed with comprehensive testing for genetic mutations that increase cancer risk, and when presented with counseling before and after testing, most make informed decisions and experience decreased levels of anxiety, according to new research from the Perelman School of Medicine at the University of Pennsylvania and the Basser Center for BRCA in Penn's Abramson Cancer Center.

WHO publishes comprehensive report on H1N1

"A year after the H1N1 [swine] flu first appeared, the World Health Organization has issued perhaps the most comprehensive report on the pandemic's activity to date," HealthDay News/Bloomberg BusinessWeek reports (Gardner, 5/5).

Read more Medical News

› Verified 7 days ago